Myocyte Enhancer Factor 2 Transcription Factors in Heart Development and Disease

Heart Development and Regeneration

Volumn , Issue , 2010, Pages 673-699

  Black, Brian L ^a   Cripps, Richard M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952334164     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381332-9.00030-X     Document Type: Chapter

References (233)

1. Ai D., Liu W., Ma L., Dong F., Lu M.F., Wang D., Verzi M.P., Cai C., Gage P.J., Evans S., Black B.L., Brown N.A., Martin J.F. Pitx2 regulates cardiac left-right asymmetry by patterning second cardiac lineage-derived myocardium. Dev. Biol. 2006, 296:437-449.
2. Ai D., Fu X., Wang J., Lu M.F., Chen L., Baldini A., Klein W.H., Martin J.F. Canonical Wnt signaling functions in second heart field to promote right ventricular growth. Proc. Natl. Acad. Sci. USA 2007, 104:9319-9324.
3. Altshuler D., Hirschhorn J.N. MEF2A sequence variants and coronary artery disease: a change of heart?. J. Clin. Invest. 2005, 115:831-833.
4. Alvarez-Buylla E.R., Pelaz S., Liljegren S.J., Gold S.E., Burgeff C., Ditta G.S., Ribas de Pouplana L., Martinez-Castilla L., Yanofsky L. An ancestral MADS-box gene duplication occurred before the divergence of plants and animals. Proc. Natl. Acad. Sci. USA 2000, 97:5328-5333.
5. Arnold M.A., Kim Y., Czubryt M.P., Phan D., McAnally J., Qi X., Shelton J.M., Richardson J.A., Bassel-Duby R., Olson E.N. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Cell 2007, 12:377-389.
6. Backs J., Olson E.N. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res. 2006, 98:15-24.
7. Basson C.T., Bachinsky D.R., Lin R.C., Levi T., Elkins J.A., Soults J., Grayzel D., Kroumpouzou E., Traill T.A., Leblanc-Straceski J., Renault B., Kucherlapati R., Seidman J.G., Seidman C.E. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat. Genet. 1997, 15:30-35.
8. Becker A., Theissen G. The major clades of MADS-box genes and their role in the development and evolution of flowering plants. Mol. Phylogenet. Evol. 2003, 29:464-489.
9. Berdeaux R., Goebel N., Banaszynski L., Takemori H., Wandless T., Shelton G.D., Montminy M. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat. Med. 2007, 13:597-603.
10. Bertos N.R., Wang A.H., Yang X.J. Class II histone deacetylases: structure, function, and regulation. Biochem. Cell Biol. 2001, 79:243-252.
11. Bhagavatula M.R., Fan C., Shen G.Q., Cassano J., Plow E.F., Topol E.J., Wang Q. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 2004, 13:3181-3188.
12. Bi W., Drake C.J., Schwarz J.J. The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev. Biol. 1999, 211:255-267.
13. Black B.L. Transcriptional pathways in second heart field development. Semin. Cell Dev. Biol. 2007, 18:67-76.
14. Black B.L., Ligon K.L., Zhang Y., Olson E.N. Cooperative transcriptional activation by the neurogenic basic helix-loop-helix protein MASH1 and members of the myocyte enhancer factor-2 (MEF2) family. J. Biol. Chem. 1996, 271:26659-26663.
15. Black B.L., Lu J., Olson E.N. The MEF2A 3' untranslated region functions as a cis-acting translational repressor. Mol. Cell Biol. 1997, 17:2756-2763.
16. Black B.L., Olson E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 1998, 14:167-196.
17. Black B.L., Molkentin J.D., Olson E.N. Multiple roles for the MyoD basic region in transmission of transcriptional activation signals and interaction with MEF2. Mol. Cell Biol. 1998, 18:69-77.
18. Borghi S., Molinari S., Razzini G., Parise F., Battini R., Ferrari S. The nuclear localization domain of the MEF2 family of transcription factors shows member-specific features and mediates the nuclear import of histone deacetylase 4. J. Cell Sci. 2001, 114:4477-4483.
19. Bour B.A., O'Brien M.A., Lockwood W.L., Goldstein E.S., Bodmer R., Taghert P.H., Abmayr S.M., Nguyen H.T. Drosophila MEF2, a transcription factor that is essential for myogenesis. Genes. Dev. 1995, 9:730-741.
20. Breitbart R.E., Liang C.S., Smoot L.B., Laheru D.A., Mahdavi V., Nadal-Ginard B. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development 1993, 118:1095-1106.
21. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., Evans S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev. Cell 2003, 5:877-889.
22. Callis T.E., Chen J.F., Wang D.Z. MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol. 2007, 26:219-225.
23. Chambers A.E., Kotecha S., Towers N., Mohun T.J. Muscle-specific expression of SRF-related genes in the early embryo of Xenopus laevis. Embo. J. 1992, 11:4981-4991.
24. Chan J.K., Sun L., Yang X.J., Zhu G., Wu Z. Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. J. Biol. Chem. 2003, 278:23515-23521.
25. Chang C.I., Xu B.E., Akella R., Cobb M.H., Goldsmith E.J. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 2002, 9:1241-12459.
26. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 2006, 38:228-233.
27. Chen S.L., Dowhan D.H., Hosking B.M., Muscat G.E. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes. Dev. 2000, 14:1209-1228.
28. Choi S.J., Park S.Y., Han T.H. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation. Nucleic. Acids. Res. 2001, 29:2836-2842.
29. Cox D.M., Du M., Marback M., Yang E.C., Chan J., Siu K.W., McDermott J.C. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J. Biol. Chem. 2003, 278:15297-15303.
30. Creemers E.E., Sutherland L.B., Oh J., Barbosa A.C., Olson E.N. Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol. Cell 2006, 23:83-96.
31. Cripps R.M., Black B.L., Zhao B., Lien C.L., Schulz R.A., Olson E.N. The myogenic regulatory gene Mef2 is a direct target for transcriptional activation by Twist during Drosophila myogenesis. Genes. Dev. 1998, 12:422-434.
32. Cripps R.M., Zhao B., Olson E.N. Transcription of the myogenic regulatory gene Mef2 in cardiac, somatic, and visceral muscle cell lineages is regulated by a Tinman-dependent core enhancer. Dev. Biol. 1999, 215:420-430.
33. Cripps R.M., Olson E.N. Control of cardiac development by an evolutionarily conserved transcriptional network. Dev. Biol. 2002, 246:14-28.
34. Cripps R.M., Lovato T.L., Olson E.N. Positive autoregulation of the Myocyte enhancer factor-2 myogenic control gene during somatic muscle development in Drosophila. Dev. Biol. 2004, 267:536-547.
35. Czubryt M.P., Olson E.N. Balancing contractility and energy production: the role of myocyte enhancer factor 2 (MEF2) in cardiac hypertrophy. Recent Prog. Horm. Res. 2004, 59:105-124.
36. Damm C., Wolk A., Buttgereit D., Loher K., Wagner E., Lilly B., Olson E.N., Hasenpusch-Theil K., Renkawitz-Pohl R. Independent regulatory elements in the upstream region of the Drosophila beta 3 tubulin gene (beta Tub60D) guide expression in the dorsal vessel and the somatic muscles. Dev. Biol. 1998, 199:138-149.
37. Davidson B. Ciona intestinalis as a model for cardiac development. Semin. Cell Dev. Biol. 2007, 18:16-26.
38. Davis R.L., Weintraub H., Lassar A.B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000.
39. De Luca A., Severino A., De Paolis P., Cottone G., De Luca L., De Falco M., Porcellini A., Volpe M., Condorelli G. p300/cAMP-response-element-binding-protein ("CREB")-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor. Biochem. J. 2003, 369:477-484.
40. De Val S., Anderson J.P., Heidt A.B., Khiem D., Xu S.M., Black B.L. Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer. Dev. Biol. 2004, 275:424-434.
41. De Val S., Chi N.C., Meadows S.M., Minovitsky S., Anderson J.P., Harris I.S., Ehlers M.L., Agarwal P., Visel A., Xu S.M., Pennacchio L.A., Dubchak I., Krieg P.A., Stainier D.Y., Black B.L. Combinatorial regulation of endothelial gene expression by Ets and Forkhead transcription factors. Cell 2008, 135:1053-1064.
42. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425:577-584.
43. Dodou E., Xu S.M., Black B.L. Mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo. Mech. Dev. 2003, 120:1021-1032.
44. Dodou E., Verzi M.P., Anderson J.P., Xu S.M., Black B.L. Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 2004, 131:3931-3942.
45. Dressel U., Bailey P.J., Wang S.C., Downes M., Evans R.M., Muscat G.E. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J. Biol. Chem. 2001, 276:17007-17013.
46. Durham J.T., Brand O.M., Arnold M., Reynolds J.G., Muthukumar L., Weiler H., Richardson J.A., Naya F.J. Myospryn is a direct transcriptional target for MEF2A that encodes a striated muscle, alpha-actinin-interacting, costamere-localized protein. J. Biol. Chem. 2006, 281:6841-6849.
47. Edmondson D.G., Lyons G.E., Martin J.F., Olson E.N. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 1994, 120:1251-1263.
48. Esau C., Boes M., Youn H.D., Tatterson L., Liu J.O., Chen J. Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells. J. Exp. Med. 2001, 194:1449-1459.
49. Fickett J.W. Coordinate positioning of MEF2 and myogenin binding sites. Gene 1996, 172:GC19-GC32.
50. Flavell S.W., Cowan C.W., Kim T.K., Greer P.L., Lin Y., Paradis S., Griffith E.C., Hu L.S., Chen C., Greenberg M.E. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 2006, 311:1008-1012.
51. Frasch M. Induction of visceral and cardiac mesoderm by ectodermal Dpp in the early Drosophila embryo. Nature 1995, 374:464-467.
52. Frasch M. Intersecting signalling and transcriptional pathways in Drosophila heart specification. Semin. Cell Dev. Biol. 1999, 10:61-71.
53. Gajewski K., Kim Y., Lee Y.M., Olson E.N., Schulz R.A. D-mef2 is a target for Tinman activation during Drosophila heart development. Embo. J. 1997, 16:515-522.
54. Gajewski K., Kim Y., Choi C.Y., Schulz R.A. Combinatorial control of Drosophila mef2 gene expression in cardiac and somatic muscle cell lineages. Dev. Genes Evol. 1998, 208:382-392.
55. Gajewski K., Choi C.Y., Kim Y., Schulz R.A. Genetically distinct cardial cells within the Drosophila heart. Genesis 2000, 28:36-43.
56. Garg V., Kathiriya I.S., Barnes R., Schluterman M.K., King I.N., Butler C.A., Rothrock C.R., Eapen R.S., Hirayama-Yamada K., Joo K., Matsuoka R., Cohen J.C., Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
57. Giglio S., Graw S.L., Gimelli G., Pirola B., Varone P., Voullaire L., Lerzo F., Rossi E., Dellavecchia C., Bonaglia M.C., Digilio M.C., Giannotti A., Marino B., Carrozzo R., Korenberg J.R., Danesino C., Sujansky E., Dallapiccola B., Zuffardi O. Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation 2000, 102:432-437.
58. Gill G. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 2005, 15:536-541.
59. Goddeeris M.M., Schwartz R., Klingensmith J., Meyers E.N. Independent requirements for Hedgehog signaling by both the anterior heart field and neural crest cells for outflow tract development. Development 2007, 134:1593-1604.
60. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L.A., Marshall J., Mao Z. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003, 38:33-46.
61. Gossett L.A., Kelvin D.J., Sternberg E.A., Olson E.N. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell Biol. 1989, 9:5022-5033.
62. Gregoire S., Yang X.J. Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell Biol. 2005, 25:2273-2287.
63. Gregoire S., Tremblay A.M., Xiao L., Yang Q., Ma K., Nie J., Mao Z., Wu Z., Giguere V., Yang X.J. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 2006, 281:4423-4433.
64. Gregoire S., Xiao L., Nie J., Zhang X., Xu M., Li J., Wong J., Seto E., Yang X.J. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell Biol. 2007, 27:1280-1295.
65. Han A., Pan F., Stroud J.C., Youn H.D., Liu J.O., Chen L. Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature 2003, 422:730-734.
66. Han A., He J., Wu Y., Liu J.O., Chen L. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J. Mol. Biol. 2005, 345:91-102.
67. Han J., Jiang Y., Li Z., Kravchenko V.V., Ulevitch R.J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997, 386:296-299.
68. Han J., Molkentin J.D. Regulation of MEF2 by p38 MAPK and its implication in cardiomyocyte biology. Trends Cardiovasc. Med. 2000, 10:19-22.
69. Hinits Y., Hughes S.M. Mef2s are required for thick filament formation in nascent muscle fibres. Development 2007, 134:2511-2519.
70. Horan P.G., Allen A.R., Hughes A.E., Patterson C.C., Spence M., McGlinchey P.G., Belton C., Jardine T.C., McKeown P.P. Lack of MEF2A Delta7aa mutation in Irish families with early onset ischaemic heart disease, a family based study. BMC Med. Genet. 2006, 7:65.
71. Horlick R.A., Benfield P.A. The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements. Mol. Cell Biol. 1989, 9:2396-2413.
72. Huang H.T., Brand O.M., Mathew M., Ignatiou C., Ewen E.P., McCalmon S.A., Naya F.J. Myomaxin is a novel transcriptional target of MEF2A that encodes a Xin-related alpha-actinin-interacting protein. J. Biol. Chem. 2006, 281:39370-39379.
73. Huang K., Louis J.M., Donaldson L., Lim F.L., Sharrocks A.D., Clore G.M. Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors. Embo. J. 2000, 19:2615-2628.
74. Ikeshima H., Imai S., Shimoda K., Hata J., Takano T. Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages. Neurosci. Lett. 1995, 200:117-120.
75. Jang H., Choi D.E., Kim H., Cho E.J., Youn H.D. Cabin1 represses MEF2 transcriptional activity by association with a methyltransferase, SUV39H1. J. Biol. Chem. 2007, 282:11172-11179.
76. Kajimoto K., Shioji K., Tago N., Tomoike H., Nonogi H., Goto Y., Iwai N. Assessment of MEF2A mutations in myocardial infarction in Japanese patients. Circ. J. 2005, 69:1192-1195.
77. Kang J., Gocke C.B., Yu H. Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity. BMC Biochem. 2006, 7:5.
78. Kao H.Y., Verdel A., Tsai C.C., Simon C., Juguilon H., Khochbin S. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J. Biol. Chem. 2001, 276:47496-47507.
79. Karamboulas C., Dakubo G.D., Liu J., De Repentigny Y., Yutzey K., Wallace V.A., Kothary R., Skerjanc I.S. Disruption of MEF2 activity in cardiomyoblasts inhibits cardiomyogenesis. J. Cell Sci. 2006, 119:4315-4321.
80. Karasseva N., Tsika G., Ji J., Zhang A., Mao X., Tsika R. Transcription enhancer factor 1 binds multiple muscle MEF2 and A/T-rich elements during fast-to-slow skeletal muscle fiber type transitions. Mol. Cell Biol. 2003, 23:5143-5164.
81. Kasler H.G., Victoria J., Duramad O., Winoto A. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol. Cell Biol. 2000, 20:8382-8389.
82. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. Embo. J. 1997, 16:7054-7066.
83. Kato Y., Zhao M., Morikawa A., Sugiyama T., Chakravortty D., Koide N., Yoshida T., Tapping R.I., Yang Y., Yokochi T., Lee J.D. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 2000, 275:18534-18540.
84. Kelly K.K., Meadows S.M., Cripps R.M. Drosophila MEF2 is a direct regulator of Actin57B transcription in cardiac, skeletal, and visceral muscle lineages. Mech. Dev. 2002, 110:39-50.
85. Kelly R.G., Buckingham M.E. The anterior heart-forming field: voyage to the arterial pole of the heart. Trends Genet. 2002, 18:210-216.
86. Khiem D., Cyster J.G., Schwarz J.J., Black B.L. A p38 MAPK-MEF2C pathway regulates B-cell proliferation. Proc. Natl. Acad. Sci. USA 2008, 105:17067-17072.
87. Kim T.G., Jung J., Mysliwiec M.R., Kang S., Lee Y. Jumonji represses alpha-cardiac myosin heavy chain expression via inhibiting MEF2 activity. Biochem. Biophys. Res. Commun. 2005, 329:544-553.
88. Kolodziejczyk S.M., Wang L., Balazsi K., DeRepentigny Y., Kothary R., Megeney L.A. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr. Biol. 1999, 9:1203-1206.
89. Kopan R., Nye J.S., Weintraub H. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 1994, 120:2385-2396.
90. Kuroda K., Tani S., Tamura K., Minoguchi S., Kurooka H., Honjo T. Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis. J. Biol. Chem. 1999, 274:7238-7244.
91. Lavine K.J., Yu K., White A.C., Zhang X., Smith C., Partanen J., Ornitz D.M. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev. Cell 2005, 8:85-95.
92. Lazaro J.B., Bailey P.J., Lassar A.B. Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation. Genes. Dev. 2002, 16:1792-1805.
93. Lee Y., Nadal-Ginard B., Mahdavi V., Izumo S. Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene. Mol. Cell Biol. 1997, 17:2745-2755.
94. Leifer D., Golden J., Kowall N.W. Myocyte-specific enhancer binding factor 2C expression in human brain development. Neuroscience 1994, 63:1067-1079.
95. Lemercier C., Verdel A., Galloo B., Curtet S., Brocard M.P., Khochbin S. MHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 2000, 275:15594-15599.
96. Leo C., Chen J.D. The SRC family of nuclear receptor coactivators. Gene 2000, 245:1-11.
97. L'Honore A., Rana V., Arsic N., Franckhauser C., Lamb N.J., Fernandez A. Identification of a new hybrid serum response factor and myocyte enhancer factor 2-binding element in MyoD enhancer required for MyoD expression during myogenesis. Mol. Biol. Cell 2007, 18:1992-2001.
98. Lilly B., Galewsky S., Firulli A.B., Schulz R.A., Olson E.N. D-MEF2: a MADS box transcription factor expressed in differentiating mesoderm and muscle cell lineages during Drosophila embryogenesis. Proc. Natl. Acad. Sci. USA 1994, 91:5662-5666.
99. Lilly B., Zhao B., Ranganayakulu G., Paterson B.M., Schulz R.A., Olson E.N. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 1995, 267:688-693.
100. Lin M.H., Nguyen H.T., Dybala C., Storti R.V. Myocyte-specific enhancer factor 2 acts cooperatively with a muscle activator region to regulate Drosophila tropomyosin gene muscle expression. Proc. Natl. Acad. Sci. USA 1996, 93:4623-4628.
101. Lin Q., Lu J., Yanagisawa H., Webb R., Lyons G.E., Richardson J.A., Olson E.N. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 1998, 125:4565-4574.
102. Lin Q., Schwarz J., Bucana C., Olson E.N. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997, 276:1404-1407.
103. Lin X., Shah S., Bulleit R.F. The expression of MEF2 genes is implicated in CNS neuronal differentiation. Brain Res. Mol. Brain Res. 1996, 42:307-316.
104. Ling Y., West A.G., Roberts E.C., Lakey J.H., Sharrocks A.D. Interaction of transcription factors with serum response factor. Identification of the Elk-1 binding surface. J. Biol. Chem. 1998, 273:10506-10514.
105. Little G.H., Bai Y., Williams T., Poizat C. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells. J. Biol. Chem. 2007, 282:7219-7231.
106. Liu D., Kang J.S., Derynck R. TGF-beta-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. Embo. J. 2004, 23:1557-1566.
107. Liu N., Olson E.N. Coactivator control of cardiovascular growth and remodeling. Curr. Opin. Cell Biol. 2006, 18:715-722.
108. Liu W., Youn H.D., Liu J.O. Thapsigargin-induced apoptosis involves Cabin1-MEF2-mediated induction of Nur77. Eur. J. Immunol. 2001, 31:1757-1764.
109. Liu Z.P., Nakagawa O., Nakagawa M., Yanagisawa H., Passier R., Richardson J.A., Srivastava D., Olson E.N. CHAMP, a novel cardiac-specific helicase regulated by MEF2C. Dev. Biol. 2001, 234:497-509.
110. Lo P.C., Frasch M. A role for the COUP-TF-related gene seven-up in the diversification of cardioblast identities in the dorsal vessel of Drosophila. Mech. Dev. 2001, 104:49-60.
111. Lo P.C., Frasch M. Establishing A-P polarity in the embryonic heart tube: a conserved function of Hox genes in Drosophila and vertebrates?. Trends Cardiovasc. Med. 2003, 13:182-187.
112. Lovato T.L., Nguyen T.P., Molina M.R., Cripps R.M. The Hox gene abdominal-A specifies heart cell fate in the Drosophila dorsal vessel. Development 2002, 129:5019-5027.
113. Lu J., McKinsey T.A., Nicol R.L., Olson E.N. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 2000, 97:4070-4075.
114. Lu J., McKinsey T.A., Zhang C.L., Olson E.N. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 2000, 6:233-244.
115. Lyons G.E., Micales B.K., Schwarz J., Martin J.F., Olson E.N. Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J. Neurosci. 1995, 15:5727-5738.
116. Ma K., Chan J.K., Zhu G., Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol. Cell Biol. 2005, 25:3575-3582.
117. Maeda T., Gupta M.P., Stewart A.F. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters. Biochem. Biophys. Res. Commun. 2002, 294:791-797.
118. Mao Z., Nadal-Ginard B. Functional and physical interactions between mammalian achaete-scute homolog 1 and myocyte enhancer factor 2A. J. Biol. Chem. 1996, 271:14371-14375.
119. Mar J.H., Ordahl C.P. M-CAT binding factor, a novel trans-acting factor governing muscle-specific transcription. Mol. Cell Biol. 1990, 10:4271-4283.
120. Marin M.C., Rodriguez J.R., Ferrus A. Transcription of Drosophila troponin I gene is regulated by two conserved, functionally identical, synergistic elements. Mol. Biol. Cell. 2004, 15:1185-1196.
121. Marinissen M.J., Chiariello M., Pallante M., Gutkind J.S. A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol. Cell Biol. 1999, 19:4289-4301.
122. Martin J.F., Schwarz J.J., Olson E.N. Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc. Natl. Acad. Sci. USA 1993, 90:5282-5286.
123. Martin J.F., Miano J.M., Hustad C.M., Copeland N.G., Jenkins N.A., Olson E.N. A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell Biol. 1994, 14:1647-1656.
124. McDermott J.C., Cardoso M.C., Yu Y.T., Andres V., Leifer D., Krainc D., Lipton S.A., Nadal-Ginard B. HMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell Biol. 1993, 13:2564-2577.
125. McKinsey T.A., Zhang C.L., Lu J., Olson E.N. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000, 408:106-111.
126. McKinsey T.A., Zhang C.L., Olson E.N. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5. Proc. Natl. Acad. Sci. USA 2000, 97:14400-14405.
127. McKinsey T.A., Zhang C.L., Olson E.N. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 2001, 11:497-504.
128. McKinsey T.A., Zhang C.L., Olson E.N. Identification of a signal-responsive nuclear export sequence in class II histone deacetylases. Mol. Cell Biol. 2001, 21:6312-6321.
129. McKinsey T.A., Zhang C.L., Olson E.N. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem. Sci. 2002, 27:40-47.
130. Miller C.T., Swartz M.E., Khuu P.A., Walker M.B., Eberhart J.K., Kimmel C.B. Mef2ca is required in cranial neural crest to effect Endothelin1 signaling in zebrafish. Dev. Biol. 2007, 308:144-157.
131. Molkentin J.D., Markham B.E. Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo. J. Biol. Chem. 1993, 268:19512-19520.
132. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 1995, 83:1125-1136.
133. Molkentin J.D., Olson E.N. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc. Natl. Acad. Sci. USA 1996, 93:9366-9373.
134. Molkentin J.D., Black B.L., Martin J.F., Olson E.N. Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C. Mol. Cell Biol. 1996, 16:2627-2636.
135. Molkentin J.D., Firulli A.B., Black B.L., Martin J.F., Hustad C.M., Copeland N., Jenkins N., Lyons G., Olson E.N. MEF2B is a potent transactivator expressed in early myogenic lineages. Mol. Cell Biol. 1996, 16:3814-3824.
136. Molkentin J.D., Li L., Olson E.N. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J. Biol. Chem. 1996, 271:17199-17204.
137. Montgomery R.L., Davis C.A., Potthoff M.J., Haberland M., Fielitz J., Qi X., Hill J.A., Richardson J.A., Olson E.N. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007, 21:1790-1802.
138. Mori A.D., Bruneau B.G. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed. Curr. Opin. Cardiol. 2004, 19:211-215.
139. Morin S., Charron F., Robitaille L., Nemer M. GATA-dependent recruitment of MEF2 proteins to target promoters. Embo. J. 2000, 19:2046-2055.
140. Morin S., Pozzulo G., Robitaille L., Cross J., Nemer M. MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters. J. Biol. Chem. 2005, 280:32272-32278.
141. Mueller P.R., Wold B. In vivo footprinting of a muscle specific enhancer by ligation mediated PCR. Science 1989, 246:780-786.
142. Mushegian A.R., Koonin E.V. Sequence analysis of eukaryotic developmental proteins: ancient and novel domains. Genetics 1996, 144:817-828.
143. Nadruz W., Kobarg C.B., Constancio S.S., Corat P.D., Franchini K.G. Load-induced transcriptional activation of c-jun in rat myocardium: regulation by myocyte enhancer factor 2. Circ. Res. 2003, 92:243-251.
144. Nakagawa O., Arnold M., Nakagawa M., Hamada H., Shelton J.M., Kusano H., Harris T.M., Childs G., Campbell K.P., Richardson J.A., Nishino I., Olson E.N. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2. Genes Dev. 2005, 19:2066-2077.
145. Navankasattusas S., Zhu H., Garcia A.V., Evans S.M., Chien K.R. A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression. Mol. Cell Biol. 1992, 12:1469-1479.
146. Naya F.J., Black B.L., Wu H., Bassel-Duby R., Richardson J.A., Hill J.A., Olson E.N. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 2002, 8:1303-1309.
147. Nguyen H.T., Bodmer R., Abmayr S.M., McDermott J.C., Spoerel N.A. D-mef2: a Drosophila mesoderm-specific MADS box-containing gene with a biphasic expression profile during embryogenesis. Proc. Natl. Acad. Sci. USA 1994, 91:7520-7524.
148. Nguyen H.T., Xu X. Drosophila mef2 expression during mesoderm development is controlled by a complex array of cis-acting regulatory modules. Dev. Biol. 1998, 204:550-566.
149. Nguyen T., Wang J., Schulz R.A. Mutations within the conserved MADS box of the D-MEF2 muscle differentiation factor result in a loss of DNA binding ability and lethality in Drosophila. Differentiation 2002, 70:438-446.
150. Olson E.N., Perry M., Schulz R.A. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev. Biol. 1995, 172:2-14.
151. Olson E.N., Backs J., McKinsey T.A. Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation. Novartis Found Symp. 2006, 274:3-12. discussion 13-19, 152-155, 272-276.
152. Ornatsky O.I., Andreucci J.J., McDermott J.C. A dominant-negative form of transcription factor MEF2 inhibits myogenesis. J. Biol. Chem. 1997, 272:33271-33278.
153. Ornatsky O.I., Cox D.M., Tangirala P., Andreucci J.J., Quinn Z.A., Wrana J.L., Prywes R., Yu Y.T., McDermott J.C. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res. 1999, 27:2646-2654.
154. Pabst S., Wollnik B., Rohmann E., Hintz Y., Glanzer K., Vetter H., Nickenig G., Grohe C. A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomal-dominant inherited congenital heart disease. Clin. Res. Cardiol. 2008, 97:39-42.
155. Park E.J., Ogden L.A., Talbot A., Evans S., Cai C.L., Black B.L., Frank D.U., Moon A.M. Required, tissue-specific roles for Fgf8 in outflow tract formation and remodeling. Development 2006, 133:2419-2433.
156. Parmacek M.S. Transcriptional programs regulating vascular smooth muscle cell development and differentiation. Curr. Top Dev. Biol. 2001, 51:69-89.
157. Pehlivan T., Pober B.R., Brueckner M., Garrett S., Slaugh R., Van Rheeden R., Wilson D.B., Watson M.S., Hing A.V. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am. J. Med. Genet. 1999, 83:201-206.
158. Pollock R., Treisman R. Human SRF-related proteins: DNA-binding properties and potential regulatory targets. Genes Dev. 1991, 5:2327-2341.
159. Quinn Z.A., Yang C.C., Wrana J.L., McDermott J.C. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res. 2001, 29:732-742.
160. Ranganayakulu G., Zhao B., Dokidis A., Molkentin J.D., Olson E.N., Schulz R.A. A series of mutations in the D-MEF2 transcription factor reveal multiple functions in larval and adult myogenesis in Drosophila. Dev. Biol. 1995, 171:169-181.
161. Rao S., Karray S., Gackstetter E.R., Koshland M.E. Myocyte enhancer factor-related B-MEF2 is developmentally expressed in B cells and regulates the immunoglobulin J chain promoter. J. Biol. Chem. 1998, 273:26123-26129.
162. Ren X., Li Y., Ma X., Zheng L., Xu Y., Wang J. Activation of p38/MEF2C pathway by all-trans retinoic acid in cardiac myoblasts. Life Sci. 2007, 81:89-96.
163. Riquelme C., Barthel K.K., Liu X. SUMO-1 modification of MEF2A regulates its transcriptional activity. J. Cell Mol. Med. 2006, 10:132-144.
164. Sandmann T., Jensen L.J., Jakobsen J.S., Karzynski M.M., Eichenlaub M.P., Bork P., Furlong E.E. A temporal map of transcription factor activity: mef2 directly regulates target genes at all stages of muscle development. Dev. Cell 2006, 10:797-807.
165. Sandmann T., Girardot C., Brehme M., Tongprasit W., Stolc V., Furlong E.E. A core transcriptional network for early mesoderm development in Drosophila melanogaster. Genes Dev. 2007, 21:436-449.
166. Santelli E., Richmond T.J. Crystal structure of MEF2A core bound to DNA at 1.5 A resolution. J. Mol. Biol. 2000, 297:437-449.
167. Sartorelli V., Huang J., Hamamori Y., Kedes L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell Biol. 1997, 17:1010-1026.
168. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., Wang J.Y., Kedes L. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 1999, 4:725-734.
169. Satyaraj E., Storb U. Mef2 proteins, required for muscle differentiation, bind an essential site in the Ig lambda enhancer. J. Immunol. 1998, 161:4795-4802.
170. Schluterman M.K., Krysiak A.E., Kathiriya I.S., Abate N., Chandalia M., Srivastava D., Garg V. Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. Am. J. Med. Genet. A 2007, 143:817-823.
171. Schott J.J., Benson D.W., Basson C.T., Pease W., Silberbach G.M., Moak J.P., Maron B.J., Seidman C.E., Seidman J.G. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998, 281:108-111.
172. Schulz R.A., Chromey C., Lu M.F., Zhao B., Olson E.N. Expression of the D-MEF2 transcription in the Drosophila brain suggests a role in neuronal cell differentiation. Oncogene 1996, 12:1827-1831.
173. Shalizi A., Gaudilliere B., Yuan Z., Stegmuller J., Shirogane T., Ge Q., Tan Y., Schulman B., Harper J.W., Bonni A. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 2006, 311:1012-1017.
174. Shen H., McElhinny A.S., Cao Y., Gao P., Liu J., Bronson R., Griffin J.D., Wu L. The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis. Genes Dev. 2006, 20:675-688.
175. Shore P., Sharrocks A.D. The MADS-box family of transcription factors. Eur. J. Biochem. 1995, 229:1-13.
176. Skerjanc I.S., Petropoulos H., Ridgeway A.G., Wilton S. Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells. J. Biol. Chem. 1998, 273:34904-34910.
177. Smith P.D., Mount M.P., Shree R., Callaghan S., Slack R.S., Anisman H., Vincent I., Wang X., Mao Z., Park D.S. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 2006, 26:440-447.
178. Srivastava D., Cserjesi P., Olson E.N. A subclass of bHLH proteins required for cardiac morphogenesis. Science 1995, 270:1995-1999.
179. Stankovic-Valentin N., Deltour S., Seeler J., Pinte S., Vergoten G., Guerardel C., Dejean A., Leprince D. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell Biol. 2007, 27:2661-2675.
180. Tang X., Wang X., Gong X., Tong M., Park D., Xia Z., Mao Z. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 2005, 25:4823-4834.
181. Taylor M.V. Muscle development. Making Drosophila muscle. Curr. Biol. 1995, 5:740-742.
182. Taylor M.V., Beatty K.E., Hunter H.K., Baylies M.K. Drosophila MEF2 is regulated by twist and is expressed in both the primordia and differentiated cells of the embryonic somatic, visceral and heart musculature. Mech. Dev. 1995, 50:29-41.
183. Theissen G., Kim J.T., Saedler H. Classification and phylogeny of the MADS-box multigene family suggest defined roles of MADS-box gene subfamilies in the morphological evolution of eukaryotes. J. Mol. Evol. 1996, 43:484-516.
184. Ticho B.S., Stainier D.Y., Fishman M.C., Breitbart R.E. Three zebrafish MEF2 genes delineate somitic and cardiac muscle development in wild-type and mutant embryos. Mech. Dev. 1996, 59:205-218.
185. Toro R., Saadi I., Kuburas A., Nemer M., Russo A.F. Cell-specific activation of the atrial natriuretic factor promoter by PITX2 and MEF2A. J. Biol. Chem. 2004, 279:52087-52094.
186. Tran C.M., Sucov H.M. The RXRalpha gene functions in a non-cell-autonomous manner during mouse cardiac morphogenesis. Development 1998, 125:1951-1956.
187. Treisman R. The SRE: a growth factor responsive transcriptional regulator. Semin. Cancer Biol. 1990, 1:47-58.
188. Trivedi C.M., Luo Y., Yin Z., Zhang M., Zhu W., Wang T., Floss T., Goettlicher M., Noppinger P.R., Wurst W., Ferrari V.A., Abrams C.S., Gruber P.J., Epstein J.A. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat. Med. 2007, 13:324-331.
189. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 2006, 103:18255-18260.
190. van Rooij E., Olson E.N. MicroRNAs put their signatures on the heart. Physiol. Genomics 2007, 31:365-366.
191. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
192. Vanpoucke G., Goossens S., De Craene B., Gilbert B., van Roy F., Berx G. GATA-4 and MEF2C transcription factors control the tissue-specific expression of the alphaT-catenin gene CTNNA3. Nucleic Acids Res. 2004, 32:4155-4165.
193. Verzi M.P., McCulley D.J., De Val S., Dodou E., Black B.L. The right ventricle, outflow tract, and ventricular septum comprise a restricted expression domain within the secondary/anterior heart field. Dev. Biol. 2005, 287:134-145.
194. Verzi M.P., Agarwal P., Brown C., McCulley D.J., Schwarz J.J., Black B.L. The transcription factor MEF2C is required for craniofacial development. Dev. Cell 2007, 12:645-652.
195. von Both I., Silvestri C., Erdemir T., Lickert H., Walls J.R., Henkelman R.M., Rossant J., Harvey R.P., Attisano L., Wrana J.L. Foxh1 is essential for development of the anterior heart field. Dev. Cell 2004, 7:331-345.
196. Vong L., Bi W., O'Connor-Halligan K.E., Li C., Cserjesi P., Schwarz J.J. MEF2C is required for the normal allocation of cells between the ventricular and sinoatrial precursors of the primary heart field. Dev. Dyn. 2006, 235:1809-1821.
197. Vong L.H., Ragusa M.J., Schwarz J.J. Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses. Genesis 2005, 43:43-48.
198. Wallin J.J., Rinkenberger J.L., Rao S., Gackstetter E.R., Koshland M.E., Zwollo P. B cell-specific activator protein prevents two activator factors from binding to the immunoglobulin J chain promoter until the antigen-driven stages of B cell development. J. Biol. Chem. 1999, 274:15959-15965.
199. Wang A.H., Bertos N.R., Vezmar M., Pelletier N., Crosato M., Heng H.H., Th'ng J., Han J., Yang X.J. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell Biol. 1999, 19:7816-7827.
200. Wang A.H., Yang X.J. Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol. Cell Biol. 2001, 21:5992-6005.
201. Wang D.Z., Valdez M.R., McAnally J., Richardson J., Olson E.N. The Mef2c gene is a direct transcriptional target of myogenic bHLH and MEF2 proteins during skeletal muscle development. Development 2001, 128:4623-4633.
202. Wang L., Fan C., Topol S.E., Topol E.J., Wang Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003, 302:1578-1581.
203. Wang Q., Rao S., Topol E.J. Miscues on the "lack of MEF2A mutations" in coronary artery disease. J. Clin. Invest. 2005, 115:1399-1400. author reply 1400-1401.
204. Wang Z., Wang D.Z., Pipes G.C., Olson E.N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. USA 2003, 100:7129-7134.
205. Ward E.J., Skeath J.B. Characterization of a novel subset of cardiac cells and their progenitors in the Drosophila embryo. Development 2000, 127:4959-4969.
206. Weng L., Kavaslar N., Ustaszewska A., Doelle H., Schackwitz W., Hebert S., Cohen J.C., McPherson R., Pennacchio L.A. Lack of MEF2A mutations in coronary artery disease. J. Clin. Invest. 2005, 115:1016-1020.
207. West A.G., Shore P., Sharrocks A.D. DNA binding by MADS-box transcription factors: a molecular mechanism for differential DNA bending. Mol. Cell Biol. 1997, 17:2876-2887.
208. Wilker P.R., Kohyama M., Sandau M.M., Albring J.C., Nakagawa O., Schwarz J.J., Murphy K.M. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat. Immunol. 2008, 9:603-612.
209. Wilson-Rawls J., Molkentin J.D., Black B.L., Olson E.N. Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol. Cell Biol. 1999, 19:2853-2862.
210. Winter B., Arnold H.H. Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 2000, 113(Pt 23):4211-4220.
211. Xin M., Davis C.A., Molkentin J.D., Lien C.L., Duncan S.A., Richardson J.A., Olson E.N. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc. Natl. Acad. Sci. USA 2006, 103:11189-11194.
212. Xu J., Li Q. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol. Endocrinol. 2003, 17:1681-1692.
213. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., Molkentin J.D. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 2006, 281:9152-9162.
214. Yan C., Takahashi M., Okuda M., Lee J.D., Berk B.C. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium. J. Biol. Chem. 1999, 274:143-150.
215. Yan C., Luo H., Lee J.D., Abe J., Berk B.C. Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains. J. Biol. Chem. 2001, 276:10870-10878.
216. Yang C.C., Ornatsky O.I., McDermott J.C., Cruz T.F., Prody C.A. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic. Acids Res. 1998, 26:4771-4777.
217. Yang Y., Jack T. Defining subdomains of the K domain important for protein-protein interactions of plant MADS proteins. Plant Mol. Biol. 2004, 55:45-59.
218. Yoshida T., Sinha S., Dandre F., Wamhoff B.R., Hoofnagle M.H., Kremer B.E., Wang D.Z., Olson E.N., Owens G.K. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 2003, 92:856-864.
219. 2+-induced release of the transcription factor MEF2. Science 1999, 286:790-793.
220. Youn H.D., Liu J.O. Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. Immunity 2000, 13:85-94.
221. Youn H.D., Grozinger C.M., Liu J.O. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4. J. Biol. Chem. 2000, 275:22563-22567.
222. Yu Y.T. Distinct domains of myocyte enhancer binding factor-2A determining nuclear localization and cell type-specific transcriptional activity. J. Biol. Chem. 1996, 271:24675-24683.
223. Yu Y.T., Breitbart R.E., Smoot L.B., Lee Y., Mahdavi V., Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 1992, 6:1783-1798.
224. Zang M.X., Li Y., Xue L.X., Jia H.T., Jing H. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C. J. Cell Biochem. 2004, 93:1255-1266.
225. Zeisberg E.M., Ma Q., Juraszek A.L., Moses K., Schwartz R.J., Izumo S., Pu W.T. Morphogenesis of the right ventricle requires myocardial expression of Gata4. J. Clin. Invest. 2005, 115:1522-1531.
226. Zhang C.L., McKinsey T.A., Lu J.R., Olson E.N. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor. J. Biol. Chem. 2001, 276:35-39.
227. Zhang C.L., McKinsey T.A., Olson E.N. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc. Natl. Acad. Sci. USA 2001, 98:7354-7359.
228. Zhang C.L., McKinsey T.A., Chang S., Antos C.L., Hill J.A., Olson E.N. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002, 110:479-488.
229. Zhao M., New L., Kravchenko V.V., Kato Y., Gram H., di Padova F., Olson E.N., Ulevitch R.J., Han J. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell Biol. 1999, 19:21-30.
230. Zhao X., Sternsdorf T., Bolger T.A., Evans R.M., Yao T.P. Regulation of MEF2 by histone deacetylase 4- and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell Biol. 2005, 25:8456-8464.
231. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220.
232. Zhu B., Gulick T. Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity. Mol. Cell Biol. 2004, 24:8264-8275.
233. Zhu B., Ramachandran B., Gulick T. Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain. J. Biol. Chem. 2005, 280:28749-28760.